ReviewAnnals of the New York Academy of Sciences2019

Vagal mechanisms as neuromodulatory targets for the treatment of metabolic disease.

Hans-Rudolf Berthoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.